Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone and Entacapone for Cognition in Schizophrenia
NCT00044083Phase 2Terminated
- Sponsor
- National Institute of Mental Health
- Start
- Aug 2002
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolcapone in schizophrenia, sponsored by National Institute of Mental Health. Started Aug 2002; status: terminated.
02
Drugs
tolcapone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00044083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044083.